We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$24.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.47B
Cap. Flow %
10.08%
Top 10 Hldgs %
39.35%
Holding
397
New
164
Increased
36
Reduced
47
Closed
100

Top Buys

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$387M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$332M
3
NOW icon
ServiceNow
NOW
+$265M
4
NYT icon
New York Times
NYT
+$189M
5
MXIM
Maxim Integrated Products
MXIM
+$152M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$456M
2
IPHI
INPHI CORPORATION
IPHI
+$311M
3
IQV icon
IQVIA
IQV
+$278M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$277M
5
EDU icon
New Oriental
EDU
+$192M

Sector Composition

Rank Sector Weight
1 Healthcare 29.51%
2 Technology 16.43%
3 Financials 13.12%
4 Communication Services 9.43%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INBX
101
DELISTED
Inhibrx, Inc. Common Stock
INBX
$15.7M 0.06%
569,328
-30,672
-5% -$639K
YMM icon
102
Full Truck Alliance
YMM
$9.1B
$15.5M 0.06%
+760,749
New +$15M
RCKT icon
103
Rocket Pharmaceuticals
RCKT
$385M
$15.5M 0.06%
350,000
– –
ZEAL
104
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$15.1M 0.06%
510,000
– –
KAHC
105
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
$14.7M 0.06%
+1,500,000
New +$14.7M
ASZ
106
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$14.6M 0.06%
+1,500,000
New +$14.7M
PLRX icon
107
Pliant Therapeutics
PLRX
$71.8M
$14.3M 0.06%
490,000
-274,262
-36% -$8.54M
ORTX
108
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$14.1M 0.06%
321,543
– –
DISA
109
DELISTED
Disruptive Acquisition Corporation I Class A Ordinary Shares
DISA
$13.6M 0.06%
+1,400,000
New +$13.6M
BEKE icon
110
KE Holdings
BEKE
$19.6B
$13M 0.05%
273,000
– –
FRXB
111
DELISTED
Forest Road Acquisition Corp. II
FRXB
$12.3M 0.05%
+1,250,000
New +$12.2M
AGGR
112
DELISTED
Agile Growth Corp
AGGR
$11.6M 0.05%
+1,200,000
New +$11.7M
DRIO icon
113
DarioHealth
DRIO
$73.4M
$11.5M 0.05%
27,000
-3,000
-10% -$1.14M
SOND
114
DELISTED
Sonder
SOND
$10.9M 0.04%
+55,000
New +$10.9M
GRND icon
115
Grindr
GRND
$2.7B
$10.8M 0.04%
1,080,000
– –
PRDS
116
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$10M 0.04%
1,000,000
– –
FWAC
117
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
$9.95M 0.04%
+1,000,000
New +$9.98M
GROV icon
118
Grove Collaborative
GROV
$41.9M
$9.79M 0.04%
+200,000
New +$9.81M
CAS
119
DELISTED
Cascade Acquisition Corp.
CAS
$9.78M 0.04%
990,000
– –
FMIV
120
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
$9.78M 0.04%
+1,000,000
New +$9.76M
ACHL
121
DELISTED
Achilles Therapeutics
ACHL
$9.76M 0.04%
996,540
-3,460
-0.3% -$46.9K
AAC
122
DELISTED
Ares Acquisition Corporation
AAC
$9.75M 0.04%
+1,000,000
New +$9.82M
CVII
123
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$9.73M 0.04%
+1,000,000
New +$9.8M
CRZN
124
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
$9.7M 0.04%
+1,000,000
New +$9.72M
LLAP
125
DELISTED
Terran Orbital Corporation
LLAP
$9.66M 0.04%
+1,000,000
New +$9.74M
3 4
5
6 7

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2021 Portfolio in Review

As of Q2 2021, Thomas Steyer held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Thomas Steyer deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.

  • Thomas Steyer's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
  • Thomas Steyer added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
  • Thomas Steyer's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
  • Thomas Steyer fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
  • Thomas Steyer's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
  • Thomas Steyer opened 164 new positions and closed 100 in Q2 2021.
  • Thomas Steyer's portfolio value rose 22% quarter-over-quarter to $24.5B.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.